Joel Pike, senior global product manager, Avantor looks at the role of excipients in enabling the shift from intravenous to subcutaneous drug delivery.
Avantor
The role of excipients in enabling the shift from intravenous to subcutaneous drug delivery
Joel Pike, senior global product manager, Avantor looks at the role of excipients in enabling the shift from intravenous to subcutaneous drug delivery.
Published:
|
4 min read
Last updated:
Sign up to our newsletter
The week's biggest stories from this industry, direct to your inbox.